Chouinard, Guy
McGill University · Université de Montréal
28 papers on CoChat
Most cited papers
- Verified
Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics
Chouinard, G., & Jones, B. D. (1980) · American Journal of Psychiatry
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 301
- Verified
Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy
Chouinard, G., Samaha, A.-N., Chouinard, V.-A., Peretti, C.-S., Kanahara, N., Takase, M., & Iyo, M. (2017) · Psychotherapy and Psychosomatics
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 270
- Verified
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics
Treatment of Major DepressionBipolar Disorder and Treatment
Cited by 265
- Verified
Alprazolam in the treatment of generalized anxiety and panic disorders: A double-blind placebo-controlled study
Chouinard, G., Annable, L., Fontaine, R., & Solyom, L. (1982) · Psychopharmacology
Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesTreatment of Major Depression
Cited by 256
- Verified
Neuroleptic-induced supersensitivity psychosis
Chouinard, G., Jones, B., & Annable, L. (1978) · American Journal of Psychiatry
Schizophrenia research and treatmentElectroconvulsive Therapy Studies
Cited by 224
- Verified
Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment
Fontaine, R., Chouinard, G., & Annable, L. (1984) · American Journal of Psychiatry
Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesSubstance Abuse Treatment and Outcomes
Cited by 176
- Verified
Atypical Antipsychotics: CATIE Study, Drug-Induced Movement Disorder and Resulting Iatrogenic Psychiatric-Like Symptoms, Supersensitivity Rebound Psychosis and Withdrawal Discontinuation Syndromes
Chouinard, G., & Chouinard, V.-A. (2008) · Psychotherapy and Psychosomatics
Schizophrenia research and treatmentTreatment of Major Depression
Cited by 168
- Verified
New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal
Chouinard, G., & Chouinard, V.-A. (2015) · Psychotherapy and Psychosomatics
Treatment of Major DepressionElectroconvulsive Therapy Studies
Cited by 164
- Verified
A Comparison of Venlafaxine, Trazodone, and Placebo in Major Depression
CUNNINGHAM, L. A., BORISON, R. L., CARMAN, J. S., CHOUINARD, G., CROWDER, J. E., DIAMOND, B. I., FISCHER, D. E., & HEARST, E. (1994) · Journal of Clinical Psychopharmacology
Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Cited by 159
- Verified
Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study
Bandelow, B., Chouinard, G., Bobes, J., Ahokas, A., Eggens, I., Liu, S., & Eriksson, H. (2010) · The International Journal of Neuropsychopharmacology
Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesTreatment of Major Depression
Cited by 142
- Verified
Therapeutic Tolerance and Rebound Psychosis During Quetiapine Maintenance Monotherapy in Patients With Schizophrenia and Schizoaffective Disorder
Margolese, H. C., Chouinard, G., Beauclair, L., & Bélanger, M.-C. (2002) · Journal of Clinical Psychopharmacology
Schizophrenia research and treatmentBipolar Disorder and Treatment
Cited by 61
- Verified
Hypnotics and Triazolobenzodiazepines - Best Predictors of High-Dose Benzodiazepine Use: Results from the Luxembourg National Health Insurance Registry
Cloos, J.-M., Bocquet, V., Rolland-Portal, I., Koch, P., & Chouinard, G. (2015) · Psychotherapy and Psychosomatics
Pharmaceutical Practices and Patient OutcomesOpioid Use Disorder Treatment
Cited by 57
- Verified
A Canadian multicenter, double-blind study of paroxetine and fluoxetine in major depressive disorder
Chouinard, G., Saxena, B., Bélanger, M.-C., Ravindran, A., Bakish, D., Beauclair, L., Morris, P., Vasavan Nair, N. P., Manchanda, R., Reesal, R., et al. (1999) · Journal of Affective Disorders
Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Cited by 57
- Verified
Patient Online Report of Selective Serotonin Reuptake Inhibitor-Induced Persistent Postwithdrawal Anxiety and Mood Disorders
Belaise, C., Gatti, A., Chouinard, V.-A., & Chouinard, G. (2012) · Psychotherapy and Psychosomatics
Treatment of Major DepressionElectroconvulsive Therapy Studies
Cited by 45
- Verified
Persistent Postwithdrawal Disorders Induced by Paroxetine, a Selective Serotonin Reuptake Inhibitor, and Treated with Specific Cognitive Behavioral Therapy
Belaise, C., Gatti, A., Chouinard, V.-A., & Chouinard, G. (2014) · Psychotherapy and Psychosomatics
Treatment of Major DepressionElectroconvulsive Therapy Studies
Cited by 44
- Verified
New concepts in benzodiazepine therapy: Rebound anxiety and new indications for the more potent benzodiazepines
Chouinard, G., Labonte, A., Fontaine, R., & Annable, L. (1983) · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesSynthesis and pharmacology of benzodiazepine derivatives
Cited by 43
- Verified
Zopiclone and Triazolam in Insomnia Associated with Generalized Anxiety Disorder: a Placebo-controlled Evaluation of Efficacy and Daytime Anxiety
FONTAINE, R., BEAUDRY, P., MORVAN, P. L., BEAUCLAIR, L., & CHOUINARD, G. (1990) · International Clinical Psychopharmacology
Sleep and related disordersAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Cited by 37
- Verified
International Task Force on Benzodiazepines
Balon, R., Chouinard, G., Cosci, F., Dubovsky, S. L., Fava, G. A., Freire, R. C., Greenblatt, D. J., Krystal, J. H., Nardi, A. E., Rickels, K., et al. (2018) · Psychotherapy and Psychosomatics
Pharmaceutical Practices and Patient OutcomesAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Cited by 35
- Verified
Withdrawal and Rebound Symptoms Associated With Abrupt Discontinuation of Venlafaxine
Dallal, A., & Chouinard, G. (1998) · Journal of Clinical Psychopharmacology
Treatment of Major DepressionElectroconvulsive Therapy Studies
Cited by 32
- Verified
Emerging clinical trends and perspectives on comorbid patterns of mental disorders in research
Fava, G. A., Tossani, E., Bech, P., Berrocal, C., Chouinard, G., Csillag, C., Wittchen, H., & Rief, W. (2014) · International Journal of Methods in Psychiatric Research
Mental Health Research TopicsMental Health Treatment and Access
Cited by 31
- Verified
A Guide to Benzodiazepine Selection. Part I: Pharmacological Aspects *
Teboul, E., & Chouinard, G. (1990) · The Canadian Journal of Psychiatry
Anesthesia and Sedative AgentsSynthesis and pharmacology of benzodiazepine derivatives
Cited by 28
- Verified
Fast-cycling bipolar disorder induced by withdrawal from long-term treatment with a tricyclic antidepressant
Jones, B. D. M., Steinberg, S. I., & Chouinard, G. (1984) · American Journal of Psychiatry
Bipolar Disorder and TreatmentTreatment of Major Depression
Cited by 26
- Verified
A Rating Scale for Psychotic Symptoms (RSPS)
Chouinard, G., & Miller, R. (1999) · Schizophrenia Research
Schizophrenia research and treatmentMental Health and Psychiatry
Cited by 26
- Verified
A Guide to Benzodiazepine Selection. Part II: Clinical Aspects
Teboul, E., & Chouinard, G. (1991) · The Canadian Journal of Psychiatry
Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesSynthesis and pharmacology of benzodiazepine derivatives
Cited by 25
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free